世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000040772

慢性疲労症候群治療薬の世界市場(2024-2028)

TechNavio

Global Chronic Fatigue Syndrome Therapeutics Market 2024-2028

発刊日 2024/07/09

言語英語

体裁PDF/145ページ

ライセンス/価格145ページ

0000040772

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

慢性疲労症候群(CFS)治療薬市場は、2023年から2028年にかけて5,460万米ドル成長すると予測されており、予測期間中にCAGRは4.51%で加速すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。CFSに対する適応外薬理学的治療の増加、CFSの危険因子の増加、CFSに関する認知度向上への取り組みなどが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ 製品別
      ◇ 鎮痛剤およびNSAID
      ◇ 抗うつ薬および抗精神病薬
      ◇ 抗菌薬および免疫調節薬
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

この調査は、CFSの新しい診断検査の開発が、今後数年間の慢性疲労症候群治療市場の成長を促進する主な理由の1つであることを特定しています。また、CFS治療用の新薬の開発とCFSにおける免疫系の役割の研究への注目の高まりにより、市場でかなりの需要が生じるでしょう。

慢性疲労症候群治療薬市場に関するレポートは、次の分野をカバーしています。

  • 慢性疲労症候群治療薬市場の規模
  • 慢性疲労症候群治療薬市場の予測
  • 慢性疲労症候群治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AIM ImmunoTech Inc.
    ➣ Apotex Inc.
    ➣ Aurobindo Pharma Ltd.
    ➣ Bionpharma Inc.
    ➣ Cadila Pharmaceuticals Ltd.
    ➣ Hikma Pharmaceuticals PLC
    ➣ Lupin Ltd.
    ➣ Pfizer Inc.
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Chronic Fatigue Syndrome Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Chronic Fatigue Syndrome Therapeutics Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 Pain relievers and NSAIDs - Market size and forecast 2023-2028
Chart on Pain relievers and NSAIDs - Market size and forecast 2023-2028 ($ million)
Data Table on Pain relievers and NSAIDs - Market size and forecast 2023-2028 ($ million)
Chart on Pain relievers and NSAIDs - Year-over-year growth 2023-2028 (%)
Data Table on Pain relievers and NSAIDs - Year-over-year growth 2023-2028 (%)
6.4 Antidepressant and antipsychotic drugs - Market size and forecast 2023-2028
Chart on Antidepressant and antipsychotic drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Antidepressant and antipsychotic drugs - Market size and forecast 2023-2028 ($ million)
Chart on Antidepressant and antipsychotic drugs - Year-over-year growth 2023-2028 (%)
Data Table on Antidepressant and antipsychotic drugs - Year-over-year growth 2023-2028 (%)
6.5 Antimicrobial and immunomodulatory drugs - Market size and forecast 2023-2028
Chart on Antimicrobial and immunomodulatory drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Antimicrobial and immunomodulatory drugs - Market size and forecast 2023-2028 ($ million)
Chart on Antimicrobial and immunomodulatory drugs - Year-over-year growth 2023-2028 (%)
Data Table on Antimicrobial and immunomodulatory drugs - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business

11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 AIM ImmunoTech Inc.
AIM ImmunoTech Inc. - Overview
AIM ImmunoTech Inc. - Product / Service
AIM ImmunoTech Inc. - Key offerings
11.4 Apotex Inc.
Apotex Inc. - Overview
Apotex Inc. - Product / Service
Apotex Inc. - Key news
Apotex Inc. - Key offerings
11.5 Bionpharma Inc.
Bionpharma Inc. - Overview
Bionpharma Inc. - Product / Service
Bionpharma Inc. - Key offerings
11.6 Cadila Pharmaceuticals Ltd.
Cadila Pharmaceuticals Ltd. - Overview
Cadila Pharmaceuticals Ltd. - Product / Service
Cadila Pharmaceuticals Ltd. - Key offerings
11.7 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
11.8 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
11.9 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.10 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
11.11 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
11.12 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus

12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Chronic Fatigue Syndrome Therapeutics Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Pain relievers and NSAIDs - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Pain relievers and NSAIDs - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Pain relievers and NSAIDs - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Pain relievers and NSAIDs - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Antidepressant and antipsychotic drugs - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Antidepressant and antipsychotic drugs - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Antidepressant and antipsychotic drugs - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Antidepressant and antipsychotic drugs - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Antimicrobial and immunomodulatory drugs - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Antimicrobial and immunomodulatory drugs - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Antimicrobial and immunomodulatory drugs - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Antimicrobial and immunomodulatory drugs - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Product ($ million)
Exhibits47: Data Table on Market opportunity by Product ($ million)
Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits49: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits51: Chart on Geographic comparison
Exhibits52: Data Table on Geographic comparison
Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits89: Market opportunity By Geographical Landscape ($ million)
Exhibits90: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits91: Impact of drivers and challenges in 2023 and 2028
Exhibits92: Overview on criticality of inputs and factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Companies covered
Exhibits96: Matrix on companies position and classification
Exhibits97: AIM ImmunoTech Inc. - Overview
Exhibits98: AIM ImmunoTech Inc. - Product / Service
Exhibits99: AIM ImmunoTech Inc. - Key offerings
Exhibits100: Apotex Inc. - Overview
Exhibits101: Apotex Inc. - Product / Service
Exhibits102: Apotex Inc. - Key news
Exhibits103: Apotex Inc. - Key offerings
Exhibits104: Bionpharma Inc. - Overview
Exhibits105: Bionpharma Inc. - Product / Service
Exhibits106: Bionpharma Inc. - Key offerings
Exhibits107: Cadila Pharmaceuticals Ltd. - Overview
Exhibits108: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits109: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits110: Hikma Pharmaceuticals Plc - Overview
Exhibits111: Hikma Pharmaceuticals Plc - Business segments
Exhibits112: Hikma Pharmaceuticals Plc - Key news
Exhibits113: Hikma Pharmaceuticals Plc - Key offerings
Exhibits114: Hikma Pharmaceuticals Plc - Segment focus
Exhibits115: Lupin Ltd. - Overview
Exhibits116: Lupin Ltd. - Product / Service
Exhibits117: Lupin Ltd. - Key news
Exhibits118: Lupin Ltd. - Key offerings
Exhibits119: Pfizer Inc. - Overview
Exhibits120: Pfizer Inc. - Product / Service
Exhibits121: Pfizer Inc. - Key news
Exhibits122: Pfizer Inc. - Key offerings
Exhibits123: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits124: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits125: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits126: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits127: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits128: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits129: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits130: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits131: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits132: Viatris Inc. - Overview
Exhibits133: Viatris Inc. - Business segments
Exhibits134: Viatris Inc. - Key news
Exhibits135: Viatris Inc. - Key offerings
Exhibits136: Viatris Inc. - Segment focus
Exhibits137: Inclusions checklist
Exhibits138: Exclusions checklist
Exhibits139: Currency conversion rates for US$
Exhibits140: Research methodology
Exhibits141: Information sources
Exhibits142: Data validation
Exhibits143: Validation techniques employed for market sizing
Exhibits144: Data synthesis
Exhibits145: 360 degree market analysis
Exhibits146: List of abbreviations

この商品のレポートナンバー

0000040772

TOP